European Hematology Association - 20th Annual Congress (June 11-14, 2015 - Vienna, Austria).
The Annual Congress of the European Hematology Association, now in its 20th year, brought together specialists in all areas of hematology research to present new data on ongoing research and share innovative ideas to aid in the treatment and diagnosis of many hematological diseases. Clinical and translational research was presented along with technological advancement in diagnostics and risk-assessment strategies. The congress afforded attendees time for networking with representatives from many disciplines associated with hematological research, including academia, industry and patient advocacy groups. This report will cover the most interesting presentations relating to therapeutics for a range of hematological conditions.
Thomson Reuters, London, UK. scientific.prousjournals@thomsonreuters.com.
G
G
Croasdell
D005060:Europe; D006405:Hematology; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy; D000081082:Phosphoinositide-3 Kinase Inhibitors; D012955:Societies, Medical; D017086:beta-Thalassemia / Q000188:drug therapy
D000081082:Phosphoinositide-3 Kinase Inhibitors
AG-348; CPL-302-215; CUDC-907; INCB-039110; INCB-040093; MOR-202; STK-405759; Sotatercept